Certified by Founder Lodge
Lassen Therapeutics
United States - San Diego, California
START UP
1 Disclosed Funding Rounds $85,000,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Lassen Therapeutics is developing novel, best-in-class biotherapeutics to improve the lives of patients suffering from serious diseases.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| December, 21 ,2023 | Series B | $85,000,000 |
Catalio Capital Management
Longitude Capital
Alta Partners
Frazier Life Sciences
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Valinor | $13,000,000 | (Dec 12, 2025)
Double (1) | $6,500,000 | (Dec 12, 2025)
Keeper | $4,000,000 | (Dec 12, 2025)
OnCorps AI | $55,000,000 | (Dec 12, 2025)
Cyphlens | $3,800,000 | (Dec 12, 2025)
